• Return to Headlines

Immunogen is Among the Companies in the Biotechnology Industry With the Lowest EPS Growth (IMGN, CELG, ALNY, BIIB, REGN)

By David Diaz

Below are the three companies in the Biotechnology industry with the lowest year-over-year expected earnings per share (EPS) growth rates. The long-term growth rate is the expected annual increase in operating EPS over the next three to five years.

Immunogen ranks lowest with a EPS growth of 0.0%. Celgene is next with a EPS growth of 22.4%. Alnylam Pharmaceuticals ranks third lowest with a EPS growth of 57.5%.

Biogen Idec follows with a EPS growth of 74.7%, and Regeneron Pharmaceuticals rounds out the bottom five with a EPS growth of 117.7%.

SmarTrend is monitoring the recent change of momentum in Alnylam Pharmaceuticals. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Alnylam Pharmaceuticals in search of a potential trend change.

Keywords: lowest eps growth immunogen Celgene alnylam pharmaceuticals Biogen Idec regeneron pharmaceuticals

Ticker(s): IMGN CELG ALNY BIIB REGN